Home / Netherlands / Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
689 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
July 31, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| November 14, 2019 | Citadel Advisors LLC | 0.52% | still open |
| November 11, 2019 | Marshall Wace LLP | 0.88% | still open |
| November 11, 2019 | Citadel Advisors LLC | 0.49% | still open |
| November 8, 2019 | AQR Capital Management, LLC | 1.58% | still open |
| November 7, 2019 | AQR Capital Management, LLC | 1.65% | still open |
| November 6, 2019 | Marshall Wace LLP | 0.99% | still open |
| November 5, 2019 | AQR Capital Management, LLC | 1.77% | still open |
| November 5, 2019 | Citadel Advisors LLC | 0.53% | still open |
| November 4, 2019 | D. E. Shaw & Co., L.P. | 1.01% | still open |
| October 31, 2019 | AQR Capital Management, LLC | 1.89% | still open |
| October 30, 2019 | Marshall Wace LLP | 1.09% | still open |
| October 29, 2019 | D. E. Shaw & Co., L.P. | 0.98% | still open |
| October 29, 2019 | Citadel Advisors LLC | 0.46% | still open |
| October 28, 2019 | D. E. Shaw & Co., L.P. | 1.00% | still open |
| October 28, 2019 | Citadel Advisors LLC | 0.59% | still open |
| October 25, 2019 | Marshall Wace LLP | 1.10% | still open |
| October 25, 2019 | Citadel Advisors LLC | 0.69% | still open |
| October 24, 2019 | D. E. Shaw & Co., L.P. | 1.10% | still open |
| October 18, 2019 | D. E. Shaw & Co., L.P. | 1.02% | still open |
| October 18, 2019 | Marshall Wace LLP | 0.90% | still open |
| October 17, 2019 | D. E. Shaw & Co., L.P. | 0.99% | still open |
| October 10, 2019 | D. E. Shaw & Co., L.P. | 1.01% | still open |
| October 9, 2019 | D. E. Shaw & Co., L.P. | 0.99% | still open |
| October 9, 2019 | Citadel Advisors LLC | 0.79% | still open |
| October 4, 2019 | D. E. Shaw & Co., L.P. | 1.01% | still open |
| October 1, 2019 | AQR Capital Management, LLC | 1.93% | still open |
| October 1, 2019 | Marshall Wace LLP | 0.81% | still open |
| September 27, 2019 | Marshall Wace LLP | 0.70% | still open |
| September 24, 2019 | Marshall Wace LLP | 0.60% | still open |
| September 20, 2019 | AQR Capital Management, LLC | 1.89% | still open |
| September 18, 2019 | AQR Capital Management, LLC | 1.90% | still open |
| September 12, 2019 | AQR Capital Management, LLC | 1.84% | still open |
| September 10, 2019 | D. E. Shaw & Co., L.P. | 0.98% | still open |
| September 9, 2019 | Citadel Advisors LLC | 0.80% | still open |
| September 6, 2019 | AQR Capital Management, LLC | 1.70% | still open |
| September 4, 2019 | D. E. Shaw & Co., L.P. | 1.00% | still open |
| September 3, 2019 | Citadel Advisors LLC | 0.71% | still open |
| August 28, 2019 | AQR Capital Management, LLC | 1.66% | still open |
| August 28, 2019 | Citadel Advisors LLC | 0.67% | still open |
| August 26, 2019 | D. E. Shaw & Co., L.P. | 0.95% | still open |
| August 23, 2019 | Citadel Advisors LLC | 0.72% | still open |
| August 19, 2019 | Citadel Advisors LLC | 0.60% | still open |
| August 16, 2019 | D. E. Shaw & Co., L.P. | 1.01% | still open |
| August 14, 2019 | Citadel Advisors LLC | 0.50% | still open |
| August 13, 2019 | D. E. Shaw & Co., L.P. | 0.91% | still open |
| August 7, 2019 | D. E. Shaw & Co., L.P. | 0.80% | still open |
| July 24, 2019 | D. E. Shaw & Co., L.P. | 0.70% | still open |
| July 23, 2019 | AQR Capital Management, LLC | 1.84% | still open |
| July 22, 2019 | D. E. Shaw & Co., L.P. | 0.60% | still open |
| July 19, 2019 | Marshall Wace LLP | 0.56% | still open |
Other companies sold short in the Netherlands
- Signify N.V. 10.57% of the capital sold short
- Akzo Nobel N.V. 8.44% of the capital sold short
- Pharming Group N.V. 8.11% of the capital sold short
- The Magnum Ice Cream Company N.V. 6.43% of the capital sold short
- Imcd N.V. 5.61% of the capital sold short
- Basic-Fit N.V. 4.23% of the capital sold short
- Fugro N.V. 4.13% of the capital sold short
- DSM-Firmenich AG 3.65% of the capital sold short
- PostNL N.V. 3.07% of the capital sold short
- Alfen N.V. 2.27% of the capital sold short
- Shell plc 2.05% of the capital sold short
- Arcadis N.V. 1.76% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=8